BRIEF-Arqule trial did not meet its primary endpoint of progression free survival
March 27, 2017 at 07:07 AM EDT
* Trial did not meet its primary endpoint of progression free survival (pfs).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.